GRMN
65
6
DAL
76
2
QCOM
73
2
PEG
53
5
NI
50
2
NWL
37
6
KEY
39
-8
CMS
60
3
FOX
35
4
HAL
58
10
GE
70
3
CF
33
4
CINF
48
5
TMO
63
3
VFC
16
3
RL
72
3
MAT
49
3
FLR
55
2
HRB
68
5
SRCL
34
-12
GRMN
65
6
DAL
76
2
QCOM
73
2
PEG
53
5
NI
50
2
NWL
37
6
KEY
39
-8
CMS
60
3
FOX
35
4
HAL
58
10
GE
70
3
CF
33
4
CINF
48
5
TMO
63
3
VFC
16
3
RL
72
3
MAT
49
3
FLR
55
2
HRB
68
5
SRCL
34
-12
Financhill
Back

First Trust NYSE Arca Biotech ETF Quote, Financials, Valuation and Earnings

MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold

The result is a select group of high-quality blue-chip stocks.
Sell
42

FBT
First Trust NYSE Arca Biotech ETF

Last Price:
144.54
Seasonality Move:
6.01%

7 Day Trial

ALL ACCESS PASS

$ 7

NOW is the time to get in on this trillion-dollar megatrend

Get it here.

First Trust NYSE Arca Biotech ETF Price Quote

$144.54
-1.21 (-0.83%)
(Updated: April 30, 2024 at 6:55 PM ET)

First Trust NYSE Arca Biotech ETF Key Stats

Sell
42
First Trust NYSE Arca Biotech ETF (FBT) is a Sell
Day range:
$144.02 - $146.64
52-week range:
$130.27 - $161.41
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
9.6K
Avg. volume:
24.1K
1-year change:
-5.12%
Market cap:
$0
Revenue:
$0
EPS:
$0

How Much Does First Trust NYSE Arca Biotech ETF Make?

Data Unavailable

Is First Trust NYSE Arca Biotech ETF Growing As A Company?

Data Unavailable

First Trust NYSE Arca Biotech ETF Stock Price Performance

What Is First Trust NYSE Arca Biotech ETF 52-Week High & Low?

First Trust NYSE Arca Biotech ETF Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy First Trust NYSE Arca Biotech ETF?

Data Unavailable

Is First Trust NYSE Arca Biotech ETF Cash Flow Positive?

Data Unavailable

First Trust NYSE Arca Biotech ETF Return On Invested Capital

Data Unavailable

First Trust NYSE Arca Biotech ETF Earnings Date & Stock Price

First Trust NYSE Arca Biotech ETF Competitors

First Trust NYSE Arca Biotech ETF Dividend Yield

Data Unavailable

First Trust NYSE Arca Biotech ETF Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable